BILLS-107hr4013eh.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (12)
fiscal year 2002
the fiscal years 2003 through 2006
5 years
October 1
2
2002
1983
biennially
1993
the 1970s
annual
many years
2002
EVENT (2)
SESSION
H. R. 4013
the ‘‘Rare Diseases Act
GPE (4)
the United States
United States
Huntington
the United States of America
NORP (1)
Americans
ORG (34)
the Public Health Service Act
National
Institutes of Health
NIH
SEC
Congress
Office
U.S.C.
an Office of Rare Diseases
Health
NORD
the House of Representatives
the ‘Office’
The Office of Rare Diseases
the Food and Drug Administra-
the National Institutes of
Health
the Office of the Director
tional Institutes of Health
An Orphan Products Board
House of Representa-
the National
Institutes of Health
the Food and Drug Admin-
Department
New Federal
the National Institutes of Health
NIH OFFICE OF RARE
Rare Diseases
Health and Human Services
LENCE
Senate
the National Organization for Rare Disorders
2
PERSON (4)
Orphan
Crohn
Duchenne
13
Lou Gehrig’s
Topic Classifications
congressional legislation
94.3%
public health
41.6%
government oversight
39.4%
Extracted Keywords
rare diseases
rare
orphan
diseases disorders
orphan drugs
diseases
disorders
drug act
drugs
office rare
national institutes
institutes health
orphan drug
institutes
medicines
Forensic Analysis
PDF Metadata
- ModDate
- D:20230115024830-05'00'
- Producer
- Acrobat Distiller 4.0 for Windows; modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20021003032758Z
Sentiment
Polarity
Positive
0.151
Subjectivity
55%
Subjective